The ability of the Geneva homologous recombination deficiency (HRD) test to predict progression-free survival (PFS) in patients with high-grade ovarian cancer treated with poly (ADP-ribose) polymerase ...
Single-cell sequencing to elucidate the disparities in the immune microenvironment between PIK3CA mutants and wild types. Sintilimab and anlotinib combination therapy in PD-L1-positive ...
The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results